Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan de Boer

Showing results (271-280 of 327) with videos related to

Pageof 33
Sort By:
American Heart Journal|June 20, 2006
Impact of infarct location on left ventricular ejection fraction after correction for enzymatic infarct size in acute myocardial infarction treated with primary coronary interventionPeter Elsman, Arnoud W J van 't Hof, Menko-Jan de Boer, et al.
The American Journal of Cardiology|April 18, 2006
Effect of coronary occlusion site on angiographic and clinical outcome in acute myocardial infarction patients treated with early coronary interventionPeter Elsman, Arnoud W J van 't Hof, Jan C A Hoorntje, et al.
BMC Cardiovascular Disorders|February 26, 2008
The importance of left ventricular function for long-term outcome after primary percutaneous coronary interventionPieter A van der Vleuten, Saman Rasoul, Willem Huurnink, et al.
American Heart Journal|June 20, 2006
Feasibility and benefit of prehospital diagnosis, triage, and therapy by paramedics only in patients who are candidates for primary angioplasty for acute myocardial infarctionArnoud W J van 't Hof, Saman Rasoul, Henri van de Wetering, et al.
Thrombosis and Haemostasis|May 12, 2005
Impact of adjunctive tirofiban administration on myocardial perfusion and mortality in patients undergoing primary angioplasty for ST-segment elevation myocardial infarctionGiuseppe De Luca, Jaap J Smit, Nicolette Ernst, et al.
Thrombosis and Haemostasis|August 9, 2006
Incidence and predictors of subacute thrombosis in patients undergoing primary angioplasty for an acute myocardial infarctionJaap Jan J Smit, Arnoud W J van 't Hof, Menko Jan de Boer, et al.
American Heart Journal|September 26, 2006
Implantable defibrillator early after primary percutaneous intervention for ST-elevation myocardial infarction: rationale and design of the Defibrillator After Primary Angioplasty (DAPA) trialJan Paul Ottervanger, Anand R Ramdat Misier, Felix Zijlstra, et al.
Biomaterials|April 2, 2013
Predicting the therapeutic efficacy of MSC in bone tissue engineering using the molecular marker CADM1Anouk Mentink, Marc Hulsman, Nathalie Groen, et al.
Scientific Reports|November 5, 2020
On the correlation between material-induced cell shape and phenotypical response of human mesenchymal stem cellsAliaksei S Vasilevich, Steven Vermeulen, Marloes Kamphuis, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|June 16, 2020
Immune Modulation by Design: Using Topography to Control Human Monocyte Attachment and Macrophage DifferentiationMatthew J Vassey, Grazziela P Figueredo, David J Scurr, et al.
Pageof 33

Showing results (271-280 of 327) with videos related to

Sort By:
Pageof 33
American Heart Journal|June 20, 2006
Impact of infarct location on left ventricular ejection fraction after correction for enzymatic infarct size in acute myocardial infarction treated with primary coronary interventionPeter Elsman, Arnoud W J van 't Hof, Menko-Jan de Boer, et al.
The American Journal of Cardiology|April 18, 2006
Effect of coronary occlusion site on angiographic and clinical outcome in acute myocardial infarction patients treated with early coronary interventionPeter Elsman, Arnoud W J van 't Hof, Jan C A Hoorntje, et al.
BMC Cardiovascular Disorders|February 26, 2008
The importance of left ventricular function for long-term outcome after primary percutaneous coronary interventionPieter A van der Vleuten, Saman Rasoul, Willem Huurnink, et al.
American Heart Journal|June 20, 2006
Feasibility and benefit of prehospital diagnosis, triage, and therapy by paramedics only in patients who are candidates for primary angioplasty for acute myocardial infarctionArnoud W J van 't Hof, Saman Rasoul, Henri van de Wetering, et al.
Thrombosis and Haemostasis|May 12, 2005
Impact of adjunctive tirofiban administration on myocardial perfusion and mortality in patients undergoing primary angioplasty for ST-segment elevation myocardial infarctionGiuseppe De Luca, Jaap J Smit, Nicolette Ernst, et al.
Thrombosis and Haemostasis|August 9, 2006
Incidence and predictors of subacute thrombosis in patients undergoing primary angioplasty for an acute myocardial infarctionJaap Jan J Smit, Arnoud W J van 't Hof, Menko Jan de Boer, et al.
American Heart Journal|September 26, 2006
Implantable defibrillator early after primary percutaneous intervention for ST-elevation myocardial infarction: rationale and design of the Defibrillator After Primary Angioplasty (DAPA) trialJan Paul Ottervanger, Anand R Ramdat Misier, Felix Zijlstra, et al.
Biomaterials|April 2, 2013
Predicting the therapeutic efficacy of MSC in bone tissue engineering using the molecular marker CADM1Anouk Mentink, Marc Hulsman, Nathalie Groen, et al.
Scientific Reports|November 5, 2020
On the correlation between material-induced cell shape and phenotypical response of human mesenchymal stem cellsAliaksei S Vasilevich, Steven Vermeulen, Marloes Kamphuis, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|June 16, 2020
Immune Modulation by Design: Using Topography to Control Human Monocyte Attachment and Macrophage DifferentiationMatthew J Vassey, Grazziela P Figueredo, David J Scurr, et al.
Pageof 33